Jasper Therapeutics, Inc.

NasdaqCM:JSPR Stock Report

Market Cap: US$361.9m

Jasper Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:JSPR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
08 Feb 24BuyUS$4,532,500Velan Capital Partners LPCompany350,000US$12.95
08 Feb 24BuyUS$2,460,500Abingworth LLPCompany190,000US$12.95
28 Nov 23BuyUS$6,486Thomas WiggansIndividual1,000US$6.49
21 Nov 23BuyUS$6,383Thomas WiggansIndividual1,000US$6.38
20 Nov 23BuyUS$18,240Thomas WiggansIndividual3,000US$6.31

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of JSPR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,1140.00738%
Individual Insiders193,4491.28%
Public Companies555,9543.69%
Hedge Funds1,747,09611.6%
VC/PE Firms3,106,65320.6%
Institutions4,042,25926.8%
General Public5,439,02836.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.8%.


Top Shareholders

Top 25 shareholders own 61.33% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.88%
Velan Capital Partners LP
1,188,500US$28.5m5.94%15.47%
7.07%
Abingworth LLP
1,066,189US$25.6m21.7%6.56%
6.54%
Soleus Capital Management, L.P.
987,096US$23.7m0%2.35%
5.65%
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
851,964US$20.4m0%1.98%
5.04%
Avidity Partners Management, L.P.
760,000US$18.2m0%0.64%
3.02%
Roche Holding AG
454,961US$10.9m0%no data
2.96%
Octagon Capital Advisors LP
446,811US$10.7m0%1.72%
2.71%
The Vanguard Group, Inc.
409,295US$9.8m7.91%no data
2.64%
Opaleye Management Inc.
398,534US$9.6m0%2.24%
2.43%
Ally Bridge Group
365,925US$8.8m16.4%2.66%
2.35%
Kingdon Capital Management, L.L.C.
354,000US$8.5m16.5%1.3%
2.11%
Bank of America Corporation, Asset Management Arm
318,005US$7.6m-0.01%no data
1.63%
Avego Healthcare Capital, LLC
245,328US$5.9m0%100.0%
1.48%
Nantahala Capital Management, LLC
222,826US$5.3m-7.27%0.47%
1.15%
Woodline Partners LP
173,299US$4.2m-42.2%0.04%
1.13%
Morgan Stanley, Investment Banking and Brokerage Investments
169,955US$4.1m118%no data
0.92%
Saturn V Capital Management LP
138,621US$3.3m-0.06%1.33%
0.88%
BlackRock, Inc.
132,397US$3.2m0.24%no data
0.77%
Judith Shizuru
115,901US$2.8m2.61%no data
0.67%
Amgen Inc.
100,993US$2.4m0%no data
0.6%
Geode Capital Management, LLC
90,447US$2.2m0%no data
0.52%
Landscape Capital Management, LLC
78,933US$1.9m0%0.15%
0.47%
Sphera Funds Management Ltd
71,306US$1.7m-87.5%0.25%
0.39%
Mariner, LLC
59,051US$1.4m-9.53%no data
0.34%
Renaissance Technologies LLC
51,432US$1.2m65.8%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.